These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 34989117)

  • 21. COVID-19: Underlying Adipokine Storm and Angiotensin 1-7 Umbrella.
    Méry G; Epaulard O; Borel AL; Toussaint B; Le Gouellec A
    Front Immunol; 2020; 11():1714. PubMed ID: 32793244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mediators of Obesity Do Not Influence SARS-CoV-2 Infection or Activation of Primary Human Lung Microvascular Endothelial Cells
    Ter Ellen BM; Niewold J; Flikweert A; Muller Kobold AC; Heeringa P; van Meurs M; Smit JM; van der Voort PHJ; Rodenhuis-Zybert IA; Moser J
    Front Immunol; 2022; 13():879033. PubMed ID: 35837388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distinguishable Immunologic Characteristics of COVID-19 Patients with Comorbid Type 2 Diabetes Compared with Nondiabetic Individuals.
    Zhao R; Sun Y; Zhang Y; Wang W; Wang S; Wang C; Liu J; Gao L; Hu Z; Fei J; Hou X; Zheng H; Chen L
    Mediators Inflamm; 2020; 2020():6914878. PubMed ID: 33061829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Obesity and diabetes as comorbidities for COVID-19: Underlying mechanisms and the role of viral-bacterial interactions.
    Kruglikov IL; Shah M; Scherer PE
    Elife; 2020 Sep; 9():. PubMed ID: 32930095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Type 2 Diabetes Contributes to Altered Adaptive Immune Responses and Vascular Inflammation in Patients With SARS-CoV-2 Infection.
    Singh M; Barrera Adame O; Nickas M; Robison J; Khatchadourian C; Venketaraman V
    Front Immunol; 2022; 13():833355. PubMed ID: 35401518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CCR2 Signaling Restricts SARS-CoV-2 Infection.
    Vanderheiden A; Thomas J; Soung AL; Davis-Gardner ME; Floyd K; Jin F; Cowan DA; Pellegrini K; Shi PY; Grakoui A; Klein RS; Bosinger SE; Kohlmeier JE; Menachery VD; Suthar MS
    mBio; 2021 Dec; 12(6):e0274921. PubMed ID: 34749524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Weight of Obesity in Immunity from Influenza to COVID-19.
    Andrade FB; Gualberto A; Rezende C; Percegoni N; Gameiro J; Hottz ED
    Front Cell Infect Microbiol; 2021; 11():638852. PubMed ID: 33816341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunopathological similarities between COVID-19 and influenza: Investigating the consequences of Co-infection.
    Khorramdelazad H; Kazemi MH; Najafi A; Keykhaee M; Zolfaghari Emameh R; Falak R
    Microb Pathog; 2021 Mar; 152():104554. PubMed ID: 33157216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanism of inflammatory response in associated comorbidities in COVID-19.
    de Lucena TMC; da Silva Santos AF; de Lima BR; de Albuquerque Borborema ME; de Azevêdo Silva J
    Diabetes Metab Syndr; 2020; 14(4):597-600. PubMed ID: 32417709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Obesity, Diabetes and COVID-19: An Infectious Disease Spreading From the East Collides With the Consequences of an Unhealthy Western Lifestyle.
    Holly JMP; Biernacka K; Maskell N; Perks CM
    Front Endocrinol (Lausanne); 2020; 11():582870. PubMed ID: 33042029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of breakthrough SARS-CoV-2 infection and clinical outcomes among vaccinated patients with type 2 diabetes.
    Bea S; Choi A; Kim JH; Cho YM; Choi WS; Jung J; Shin JY
    Diabetes Obes Metab; 2023 Sep; 25(9):2734-2742. PubMed ID: 37312652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SARS-CoV-2 infection and obesity: Common inflammatory and metabolic aspects.
    Michalakis K; Ilias I
    Diabetes Metab Syndr; 2020; 14(4):469-471. PubMed ID: 32387864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SARS-CoV-2 Infection and High-Risk Non-Muscle-Invasive Bladder Cancer: Are There Any Common Features?
    Busetto GM; Porreca A; Del Giudice F; Maggi M; D'Agostino D; Romagnoli D; Musi G; Lucarelli G; Palmer K; Colonna di Paliano A; Muto M; Hurle R; Terracciano D; de Cobelli O; Sciarra A; De Berardinis E; Ferro M
    Urol Int; 2020; 104(7-8):510-522. PubMed ID: 32516772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Obesity as an adipose tissue dysfunction disease and a risk factor for infections - Covid-19 as a case study.
    Landecho MF; Marin-Oto M; Recalde-Zamacona B; Bilbao I; Frühbeck G
    Eur J Intern Med; 2021 Sep; 91():3-9. PubMed ID: 33858724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Type 2 diabetes and its genetic susceptibility are associated with increased severity and mortality of COVID-19 in UK Biobank.
    Lee A; Seo J; Park S; Cho Y; Kim G; Li J; Liang L; Park T; Chung W
    Commun Biol; 2024 Jan; 7(1):122. PubMed ID: 38267566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The endocrine and metabolic link between COVID-19, diabetes and obesity].
    Weis N; Thorsteinsson K; Martinussen C; Madsbad S
    Ugeskr Laeger; 2020 Jul; 182(29):. PubMed ID: 32734864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Environmental pollution and COVID-19: the molecular terms and predominant disease outcomes of their sweetheart agreement.
    Colacci A; Bortone G; Maffei G; Marchesi S; Mescoli A; Parmagnani F; Pillo G; Ranzi A; Rotondo F; Serra S; Vaccari M; Zauli Sajani S; Mascolo MG; Jacobs MN
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):169-182. PubMed ID: 33412808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. COVID-19 pandemic, coronaviruses, and diabetes mellitus.
    Muniyappa R; Gubbi S
    Am J Physiol Endocrinol Metab; 2020 May; 318(5):E736-E741. PubMed ID: 32228322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Soluble Neuropilin-1 Response to Hypoglycemia in Type 2 Diabetes: Increased Risk or Protection in SARS-CoV-2 Infection?
    Moin ASM; Al-Qaissi A; Sathyapalan T; Atkin SL; Butler AE
    Front Endocrinol (Lausanne); 2021; 12():665134. PubMed ID: 34248841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bacterial co-infections in community-acquired pneumonia caused by SARS-CoV-2, influenza virus and respiratory syncytial virus.
    Hedberg P; Johansson N; Ternhag A; Abdel-Halim L; Hedlund J; Nauclér P
    BMC Infect Dis; 2022 Jan; 22(1):108. PubMed ID: 35100984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.